Prepared by Jeffrey Fortkamp, Esq., Attorney at Graff & McGovern, LPA Back in 1964, the U.S. Supreme Court reversed an Ohio Supreme Court opinion and held that a film with an explicit love scene was not obscene. In his now famous statement on pornography, Justice…
Prepared by: Jeffrey Fortkamp, Esq. Back in July 2025, we shared with you Finally, a Path Forward: Ohio Board of Nursing Opens the Door to Lifting Permanent Practice Restrictions. As a new associate with the Firm and having recently assisted several nurses with their application…
Prepared by: Brandon M. Smith, Esq. & Simone Armour Graff & McGovern, LPA recently obtained reversals in two separate Ohio administrative appeals—decisions that highlight practical constraints on agency action and the importance of a complete record on review. 1) Hancock County Common Pleas reverses “substantiated…
Prepared by: Jim McGovern Esq. & Simone Armour For decades, the Ohio Board of Nursing (OBN) held firm: Permanent Practice Restrictions (PPRs) were just that, permanent. Nurses who had served their discipline, satisfied monitoring conditions, and proven rehabilitation were still left with career-long limitations, no…
Effective April 30, 2025, The State Medical Board of Ohio has amended Rule 4731-31-01, marking a significant shift in how physicians and physician assistants are expected to evaluate and clear youth athletes following a concussion. What Changed? The 2022 Amsterdam Consensus Statement on Concussion in…
Prepared By: Jim McGovern Esq., & Simone Armour During the five minutes it takes to read this article, someone in the U.S. will die from a drug overdose—and there’s nearly a 72% chance it’s fentanyl-related.[1] Healthcare workers are not immune to this crisis. In fact,…
Prepared By: Jim McGovern, Esq. & Simone Armour Effective March 21, 2025, the Ohio Board of Nursing (“OBN”) has adopted a new enforcement posture based on authority that has existed in the statute since at least September 2024. Specifically, the OBN is now fully exercising…
Prepared By: Simone Armour & James McGovern, Esq. The Market Surge and Regulatory Pressures The GLP-1 receptor agonist market is booming. By 2035, it is expected to reach $157.5 billion. This surge in demand places immense pressure on independent pharmacies that operate in an increasingly…
Prepared by: Simone Armour and James McGovern, Esq. Overview Congress is advancing H.R. 27, the HALT Fentanyl Act, to permanently classify fentanyl-related substances (FRS) as Schedule I drugs under the Controlled Substances Act. This marks a major shift in federal drug policy, with significant compliance and…
Date: January 20, 2025Prepared by: Simone Armour and James McGovern The Ohio State Dental Board (OSDB) recently convened to discuss proposed changes to its specialty advertising rules in light of ongoing litigation. The American Academy of Implant Dentistry v. Kamdar case has challenged the OSDB’s…
